Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...

A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

A new drug could prevent patients needing radical surgery to remove the organ.

A breakthrough in bladder cancer treatment is helping save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year. 17,000 will die from ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

When bladder cancer metastasizes, it can cause pain in the areas it spreads to — mainly the lymph nodes, pelvis, lungs, liver, and bones. The severity of the pain can vary, too, depending on how ...

For people with non–muscle invasive bladder cancer (NMIBC), the reality can be especially pronounced. The disease is often persistent, requiring repeated treatments, frequent monitoring, and ongoing ...

The National Institute for Health and Care Excellence (NICE) published draft guidance recommending avelumab (Bavencio, Merck Serono) for the treatment of certain forms of bladder cancer. Adults with ...